HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

SAR studies of 2-arylthiazolidine-4-carboxylic acid amides: a novel class of cytotoxic agents for prostate cancer.

Abstract
In our continuing efforts to develop novel chemotherapeutic agents for prostate cancer, recently we reported the discovery of 2-arylthiazolidine-4-carboxylic acid amides (ATCAAs) as a new class of cytotoxic agents. Several of them were very effective in killing specific human prostate cancer cell lines with low/sub-micromolar cytotoxicity and high selectivity against control cells in our sulforhodamine B assay. Encouraged with these preliminary results, we decided to further optimize this new scaffold to enhance the potency and selectivity. Current work describes the synthesis, SAR, and biological evaluation of new compounds for their ability to inhibit the growth of five human prostate cancer cell lines. The cytotoxicity data demonstrated that ATCAAs are sensitive to simple modifications or changes, which allowed us to understand the minimum structural requirements of this class of compounds to exhibit potent and selective anticancer activity against prostate cancer cells.
AuthorsVeeresa Gududuru, Eunju Hurh, Joshua Sullivan, James T Dalton, Duane D Miller
JournalBioorganic & medicinal chemistry letters (Bioorg Med Chem Lett) Vol. 15 Issue 18 Pg. 4010-3 (Sep 15 2005) ISSN: 0960-894X [Print] England
PMID16005217 (Publication Type: Journal Article, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • Amides
  • Antineoplastic Agents
  • Carboxylic Acids
Topics
  • Amides (chemistry, pharmacology, toxicity)
  • Antineoplastic Agents (chemistry, classification, pharmacology, toxicity)
  • Carboxylic Acids (chemistry)
  • Cell Line
  • Cell Proliferation (drug effects)
  • Humans
  • Inhibitory Concentration 50
  • Male
  • Molecular Structure
  • Prostatic Neoplasms (pathology)
  • Structure-Activity Relationship

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: